Justin T. Jordan

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

Eric Legius, Ludwine Messiaen, P. Wolkenstein et al. · Genetics in Medicine · 2021 · 771 citations · Full text

Medicine, Dermatology, Ophthalmology +14

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

Philipp Karschnia, Justin T. Jordan, Deborah Forst et al. · Blood · 2019 · 347 citations · Full text

Life Sciences, Immunology, Neurology +16

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

Scott R. Plotkin, Ludwine Messiaen, Eric Legius et al. · Genetics in Medicine · 2022 · 276 citations · Full text

Medicine, Genetics, Neurology +16

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Lakshmi Nayak, Annette M. Molinaro, Katherine B. Peters et al. · Clinical Cancer Research · 2020 · 257 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

Justin T. Jordan, Wei Sun, S. Farzana Hussain et al. · Cancer Immunology Immunotherapy · 2007 · 243 citations · Full text

Life Sciences, Immunology, Oncology +16